ATE392429T1 - Lebend-impfstoff gegen heliobacter pylori - Google Patents

Lebend-impfstoff gegen heliobacter pylori

Info

Publication number
ATE392429T1
ATE392429T1 AT97940148T AT97940148T ATE392429T1 AT E392429 T1 ATE392429 T1 AT E392429T1 AT 97940148 T AT97940148 T AT 97940148T AT 97940148 T AT97940148 T AT 97940148T AT E392429 T1 ATE392429 T1 AT E392429T1
Authority
AT
Austria
Prior art keywords
vaccine against
live vaccine
heliobacter pylori
pylori
against heliobacter
Prior art date
Application number
AT97940148T
Other languages
English (en)
Inventor
Thomas Meyer
Rainer Haas
Zhengxin Yan
Oscar Gomez-Duarte
Bernadette Lucas
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of ATE392429T1 publication Critical patent/ATE392429T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT97940148T 1996-10-11 1997-09-01 Lebend-impfstoff gegen heliobacter pylori ATE392429T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96116337A EP0835928A1 (de) 1996-10-11 1996-10-11 Helicobacter Pylori Lebendimpfstoff

Publications (1)

Publication Number Publication Date
ATE392429T1 true ATE392429T1 (de) 2008-05-15

Family

ID=8223286

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97940148T ATE392429T1 (de) 1996-10-11 1997-09-01 Lebend-impfstoff gegen heliobacter pylori

Country Status (15)

Country Link
EP (2) EP0835928A1 (de)
JP (1) JP2001510986A (de)
KR (1) KR100510928B1 (de)
CN (1) CN1215167C (de)
AT (1) ATE392429T1 (de)
AU (1) AU734635B2 (de)
BR (1) BR9713254A (de)
CA (1) CA2268033A1 (de)
DE (1) DE69738641D1 (de)
IL (1) IL129366A0 (de)
NO (1) NO991692L (de)
NZ (1) NZ335050A (de)
PL (1) PL332575A1 (de)
TR (1) TR199901450T2 (de)
WO (1) WO1998016552A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248551B1 (en) * 1997-03-28 2001-06-19 Institut Pasteur Helicobacter aliphatic amidase AmiE polypeptides, and DNA sequences encoding those polypeptides
US6585975B1 (en) * 1998-04-30 2003-07-01 Acambis, Inc. Use of Salmonella vectors for vaccination against helicobacter infection
EP1105159A2 (de) * 1998-06-19 2001-06-13 Mérieux Oravax Lt und ct in verfahren zur parenteralen immunisierung gegen helicobacter-infektionen
AU8464398A (en) * 1998-07-16 2000-02-07 Cheil Jedang Corporation Urease based vaccine against (helicobacter) infection
DE60124526D1 (de) * 2000-04-27 2006-12-28 Max Planck Gesellschaft Methode zur identifizierung von helicobacter antigenen
BR112013015009B1 (pt) * 2010-12-22 2020-11-10 Intervet International B.V vacina para proteger um animal contra uma doença clínica decorrente de uma infecção com bordetella bronchiseptica
CA2832115C (en) 2011-04-08 2021-03-02 Tufts Medical Center, Inc. Pepducin design and use
JP7621728B2 (ja) 2015-11-13 2025-01-27 オアシス ファーマシューティカルズ, エルエルシー プロテアーゼ活性化受容体2のモジュレーター
CN112048008B (zh) * 2020-08-12 2021-06-15 河北医科大学第四医院(河北省肿瘤医院) 一种幽门螺杆菌b细胞耐受表位及其制备的抗体
CN112143741B (zh) * 2020-09-07 2022-09-20 中国科学院南海海洋研究所 一种生物膜基因岛GIVal43097及其切除方法
CN112190704B (zh) * 2020-10-13 2022-11-15 宁夏医科大学 M细胞靶向性重组乳酸菌疫苗及制备方法与应用
CN112143750B (zh) * 2020-10-13 2022-12-27 宁夏医科大学 靶向m细胞的重组乳酸菌表面展示系统、重组乳酸菌疫苗及制备方法与应用
CN114540520A (zh) * 2022-03-22 2022-05-27 北京中瑞恒达科技有限公司 检测粪便中幽门螺杆菌的引物和探针及其试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695983A (en) * 1990-12-18 1997-12-09 The General Hospital Corporation Salmonella vaccines
DE4041045A1 (de) * 1990-12-20 1992-07-02 Max Planck Gesellschaft Zweiphasen-systeme fuer die produktion und praesentation von fremdantigen in hybriden lebendimpfstoffen
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
US5348867A (en) * 1991-11-15 1994-09-20 George Georgiou Expression of proteins on bacterial surface
WO1995014093A1 (en) * 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
EP0654273A1 (de) * 1993-11-18 1995-05-24 Harry H. Leveen Pharmazeutisches Produkt und Behandlungsverfahren
AU5523196A (en) * 1995-02-27 1996-09-18 Enteron Limited Partnership Methods and compositions for production of customized vaccines for diseases associated with antigens of microorganisms
KR19990008155A (ko) * 1995-04-28 1999-01-25 랜스 고든 다가, 재조합 우레아제 백신

Also Published As

Publication number Publication date
KR100510928B1 (ko) 2005-08-31
CN1215167C (zh) 2005-08-17
NZ335050A (en) 2000-08-25
PL332575A1 (en) 1999-09-27
TR199901450T2 (xx) 1999-10-21
EP0931093A1 (de) 1999-07-28
JP2001510986A (ja) 2001-08-07
AU4208497A (en) 1998-05-11
CA2268033A1 (en) 1998-04-23
NO991692D0 (no) 1999-04-09
NO991692L (no) 1999-06-04
AU734635B2 (en) 2001-06-21
IL129366A0 (en) 2000-02-17
EP0931093B1 (de) 2008-04-16
BR9713254A (pt) 1999-11-03
EP0835928A1 (de) 1998-04-15
CN1246867A (zh) 2000-03-08
KR20000049090A (ko) 2000-07-25
WO1998016552A1 (en) 1998-04-23
DE69738641D1 (de) 2008-05-29

Similar Documents

Publication Publication Date Title
GB2303854B (en) Helicobacter proteins and vaccines
PL304419A1 (en) Urease based vaccine against heliobacter infections
DE69738641D1 (de) Lebend-impfstoff gegen heliobacter pylori
DK0639640T3 (da) Fjerkrævaccine indeholdende smitsomt bronchitis-virus serotype 4/91
DK0835930T3 (da) Europæiske vaccinestammer af porcint reproduktions- og respirationssyndrom-virus. (PRRSV)
BR9710012B1 (pt) vacina veterinária viva recombinante e fórmula de vacina multivalente.
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
DE69333028D1 (de) Deletionsmutanten als impfstoffe gegen cholera
DK0745387T3 (da) Adjuvanser til virale vacciner
ID24174A (id) Vector dari porcine adenovirus
ATE262924T1 (de) Streptokokken c5a peptidase impfstoff
NZ314585A (en) Method of treating H. Pylori associated gastroduodenal disease
ATE377428T1 (de) Rotavirus-impfstoff
HU9701586D0 (en) Improved inactivated vaccines
ATE334697T1 (de) Boviner atmungs- und darmcoronavirus als impfstoff
SE9604322D0 (sv) Bacterial antigens and vaccine compositions II
GB9818133D0 (en) Vaccine
ATE211923T1 (de) Parenterale immunisierung gegen rotavirus
FR2719998B1 (fr) Composition immunisante anti-hélicobacter pylori à base de catalase.
SE9702240D0 (sv) Vaccine compositions III

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties